Read + Share
Altundag K. Multigene panel testing might explain the increased risk of secondary
malignancies after radiotherapy in Japanese breast cancer patients. Breast Cancer Res Treat 2022 Sep 10. pii: 10.1007/s10549-022-06742.
PMID: 36088444
|
 |
|
Altundag K. Multigene panel testing might explain the increased risk of secondary
malignancies after radiotherapy in Japanese breast cancer patients. Breast Cancer Res Treat 2022 Sep 10. pii: 10.1007/s10549-022-06742.
PMID: 36088444
|
|
|
|